
The Merkel cells, which are located at the base of the epidermis (the outermost layer of the skin), are the source of Merkel cell carcinoma (MCC), an uncommon and aggressive form of skin cancer. These cells contribute to touch perception and are linked to nerve endings. When MCC develops on sun-exposed skin, it usually appears as a rapidly growing, painless nodule on the face, head, or neck.
Due to its high level of aggression and ability to spread quickly to other regions of the body (metastasise), Merkel Cell Carcinoma (MCC) must be treated promptly. Treatment effectiveness and better results are more likely to occur when the earlier MCC is identified and treated. Postponing treatment might cause the cancer to spread, making it harder to manage and decreasing the chances of survival.
The patient's quality of life can be significantly enhanced, metastases can be avoided, and the possibility of recurrence can be reduced with early intervention, usually through surgery, radiation, or immunotherapy.
Early identification and treatment are crucial for MCC patients to have the best chance of recovery.
The exact cause of Merkel cell carcinoma (MCC) isn't completely understood, but several factors are involved in its development:
Causes
Risk Factors
Recent advancements in the prevention and treatment of Merkel Cell Carcinoma have been promising, particularly concerning photodynamic therapy (PDT). PDT is a less intrusive treatment with fewer side effects that targets and kills cancer cells using light-sensitive medications and a unique light source. India is at the forefront of innovative skin cancer treatments, leveraging nanotechnology and cellular biotechnology to enhance therapeutic outcomes. Nanotechnology, with its use of nanoparticles, offers precise drug delivery systems that target cancer cells while minimising side effects. The latest research on MCC treatment in India includes sophisticated radiation techniques, immunotherapies, and targeted therapeutics.
These developments provide more effective, individualised treatment plans, improving patients' quality of life and survival rates.
Taking proactive steps to shield your skin from damaging UV rays and preserving the general health of your skin is key to preventing MCC. Here are some tips:
Sun Protection
Regular Skin Checks
Healthy Lifestyle
Generally, Merkel cell carcinoma (MCC) treatment depends upon your overall health and its stage.
Mohn Surgery: It's a precise procedure that preserves as much healthy tissue as possible while removing the tumour and skin layers.
Wide Local Excision: This procedure removes the tumour and some surrounding healthy tissue.
Lymphadenectomy (Lymph Node Dissection): Lymph nodes are removed if the cancer has spread to them.
Immunotherapy : Immunotherapy restores your immune system to help fight the cancer.
Cost Start From USD 3000 - USD 5000Explore Options
Radiation Therapy- Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy.
Chemotherapy : Advanced or metastatic MCC may be treated with conventional chemotherapy medications, although these are less frequently utilised than immunotherapy or targeted therapy. Chemotherapy kills cancer cells that divide quickly and can be given orally or intravenously.
Cost Start From USD 600 - USD 700Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
MediRehab (chain of Rehab centres - Part of MediGence) that provides comprehensive rehabilitation services designed to support MCC patients in India. These services include:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Pune, India
Ruby Hall Clinic located in Pune, India is accredited by NABH. Also listed below are some of the most prominent infrastructural details:

Hyderabad, India
Yashoda Hospital, Malakpet located in Hyderabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Ghaziabad, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Depending on the size of the tumour, the stage at diagnosis, and the extent of the cancer's spread, a person with Merkel Cell Carcinoma (MCC) may have a shorter life expectancy.
After radiation therapy and surgery, the prognosis for early-stage MCC is generally good, with a high survival rate. Despite recent dramatic improvements in survival rates due to immunotherapy and targeted treatments, the outlook for advanced or metastatic MCC can be more cautious.
Localised MCC has a 5-year survival rate of 60–80% overall, whereas advanced stages have a lower survival rate.
The diagnosis stage, treatment type, and unique patient characteristics all affect the success rate of Merkel cell carcinoma (MCC) treatment in India.
Localised MCC has a survival rate of over 90%, and the 5-year survival rate for early-stage MCC is often relatively high, comparable to global figures.
The survival percentage for regional MCC is lower, at 60–70%, when cancer has spread to nearby lymph nodes.
The survival rate for advanced-stage MCC is significantly lower, usually between 20 and 30 %, when the cancer has spread to distant organs.
Among skin cancers, Merkel cell carcinoma (MCC) is relatively uncommon in India. It is more prevalent in skin regions exposed to sunlight and mainly affects older people. Because of its aggressive nature and metastatic potential, MCC is a serious issue, even if it is not as common as other cancers.
For better outcomes, early detection and prompt treatment are needed.
MCC, or Merkel cell carcinoma, is characterised by its aggressiveness and quick proliferation. In addition to distant organs like the brain, liver, lungs, and bones, it can swiftly spread to neighbouring lymph nodes. Controlling the spread and enhancing results depend heavily on early detection and timely treatment.
Curing Merkel cell cancer (MCC) is possible, mainly if diagnosed early and treated. With a greater chance of successful treatment, the prognosis for localised MCC is better. However, when the cancer advances to more advanced stages, the likelihood of a cure declines.
Localised MCC has a 5-year survival rate above 90%, while early-stage MCC often has a relatively high 5-year survival rate.
The survival rate is between 60 and 70% for regional MCC, where cancer has disseminated to neighbouring lymph nodes.
The survival percentage for advanced-stage MCC, where the disease has spread to distant organs, is significantly lower and usually between 20 and 30 %.
In India, recovery times following Merkel cell carcinoma (MCC) surgery can differ depending on the procedure's scope and personal circumstances. Recovery from localised MCC typically takes a few weeks. Recovery could take longer, possibly several months, if lymph nodes are affected and further surgery or radiation therapy is needed.